Systematic review of 5 observational studies (4 meta-analysed for mortality) in heart transplant recipients: aspirin vs no aspirin was associated with lower all-cause mortality (HR 0.31, 95% CI 0.15–0.67); no significant association with CAV-related outcomes (exploratory).
Meta-analysisn = 5 studies
Fournier et al. Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta-analysis